Taylor Sandison - Concepedia

Author

Taylor Sandison

Cidara Therapeutics (United States)

Also Known As

Taylor G Sandison, Taylor G. Sandison, Taylor Sandison, Taylor G. Sandison

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Cidara Therapeutics (United States)University of Washington University of California, San Francisco Makerere University Centers for Disease Control and Prevention

About

Taylor Sandison is an author at Cidara Therapeutics (United States) specializing in medicine, public health, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	406
2	Public Health	4	4	233
3	Epidemiology	2	2	168
4	Biostatistics	1	1	37
5	Clinical Nutrition	1	1	28

Taylor Sandison

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial George R. Thompson, Àlex Soriano, Oliver A. Cornely, The Lancet Translational MedicineAntifungal AgentAntifungal AgentsRezafungin Versus CaspofunginRandomised Phase 3	2022	150
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults Taylor Sandison, Voon Ong, Jonathan Lee, Antimicrobial Agents and Chemotherapy	2016	149
Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort Steven A. Pergam, Chia C. Wang, Carolyn Gardella, American Journal of Obstetrics and Gynecology Hepatitis CMaternal ComplicationClinical EpidemiologyReproductive HealthGynecology	2008	146
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial George R. Thompson, Àlex Soriano, Athanasios Skoutelis, Clinical Infectious Diseases	2020	144
Artemether‐Lumefantrine versus Dihydroartemisinin‐Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children Emmanuel Arinaitwe, Taylor Sandison, Humphrey Wanzira, Clinical Infectious Diseases	2009	123
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials George R. Thompson, Àlex Soriano, Patrick M. Honoré, The Lancet Infectious Diseases	2023	60
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study Emmanuel Arinaitwe, Anne Gasasira, Wendy Verret, Malaria Journal	2012	59
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata Justin Bader, Elizabeth A. Lakota, Shawn D. Flanagan, Antimicrobial Agents and Chemotherapy	2018	44
Using computerized clinical decision support for latent tuberculosis infection screening Andy W. Steele, Sheri Eisert, Art Davidson, American Journal of Preventive Medicine MedicineDecision AidTuberculosis PreventionDigital HealthDiagnosis	2005	37
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children Shereen Katrak, Anne Gasasira, Emmanuel Arinaitwe, Malaria Journal	2009	33

Page 1